<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827316</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00058</org_study_id>
    <nct_id>NCT04827316</nct_id>
  </id_info>
  <brief_title>Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)</brief_title>
  <acronym>PREDICT-CT</acronym>
  <official_title>Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators retrospectively and prospectively collect information from&#xD;
      enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac&#xD;
      imaging with laboratory markers and clinical data including outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators retrospectively and prospectively collect information from&#xD;
      enrolled subjects through a period of a total of 10 years to evaluate multidimensional&#xD;
      associations between phenotypic manifestations of cardiovascular disease via CCTA and cardiac&#xD;
      and non-cardiac imaging, serum biomarkers, demographic and clinical information, clinical&#xD;
      presentation (cross-sectional), therapy changes (time-varying) and their ability to predict&#xD;
      mortality and MACE (major adverse cardiac event ) (longitudinal) in patients clinically&#xD;
      indicated for CCTA.&#xD;
&#xD;
      The aim is to establish a comprehensive cross-sectional, time-varying and longitudinal data&#xD;
      collection for individuals undergoing clinically-indicated CCTA to date in order to apply&#xD;
      novel multiparametric approaches to determine cardiovascular significance to&#xD;
      clinically-important patient-centered events. For data collection this registry will follow a&#xD;
      standard CRF (case report form) structure, so to enable the merging of this data-set with&#xD;
      other international registries, which might contribute in overcoming some gaps of knowledge&#xD;
      from previous CCTA studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2031</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2031</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>All-cause death.</measure>
    <time_frame>10 years</time_frame>
    <description>The primary endpoint is the time to first occurrence of death from all-causes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular events (MACE)</measure>
    <time_frame>10 years</time_frame>
    <description>The secondary composite endpoint is major adverse cardiac events (MACE), which is defined by the occurrence of any of the following events:&#xD;
All-cause death&#xD;
Myocardial infarction&#xD;
Unstable angina-related hospitalization&#xD;
Late coronary revascularization (≥90 days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other outcome</measure>
    <time_frame>10 years</time_frame>
    <description>Occurrence of any of the following events:&#xD;
Cerebrovascular accident&#xD;
Valvular intervention&#xD;
Congestive heart failure-related hospitalization&#xD;
Cardiac death</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4200</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Arteriosclerosis</condition>
  <condition>Coronary; Ischemic</condition>
  <arm_group>
    <arm_group_label>Patients undergoing clinically indicated CCTA</arm_group_label>
    <description>Patients undergoing clinically indicated CCTA</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The registry foreseen a prospective cohort composed by patients undergoing clinically&#xD;
        indicated CCTA and by a retrospective population of patients that have undergone CCTA 1st&#xD;
        June 2017 to 31st December 2020. The principal investigator confirms that no patient's&#xD;
        personal health data will be collected if a written or documented oral refusal exist.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult individual &gt;18 years&#xD;
&#xD;
          -  Undergoing clinically indicated CCTA&#xD;
&#xD;
          -  Signed informed consent or waiver&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Gräni, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, University Hospital Bern,</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Gräni, MD, PHD</last_name>
    <phone>+41 31 632 4508</phone>
    <email>christoph.graeni@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology, University Hospital Bern, Inselspital, Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Gräni, Prof</last_name>
      <phone>+41316324508</phone>
      <email>christoph.graeni@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Computed Tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

